Clinical Trial Update: Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study to evaluate whether coadministration of darunavir/ritonavir or lopinavir/ritonavir affects the pharmacokinetics of daclatasvir in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daclatasvir (daclatasvir)
• Darunavir (darunavir)
• Lopinavir (lopinavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2015-11-30